BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.72
+1.23%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.90x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 3.40x
Liquidity & coverage
- Current ratio
- 12.09x
- Quick ratio
- 12.09x
- Cash ratio
- 10.57x
- Interest coverage
- -815.89x
- EBITDA / interest
- -692.24x
- Working capital
- $493.1M
Cash & dividend
- FCF / debt
- -13.55x
- Cash flow / debt
- -13.59x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026